Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buccal Misoprostol for Preventing Postpartum Hemorrhage in C-Section
NCT01733329Phase 4Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Feb 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) and uterine atony comparing Misoprostol with Placebo (2 arms). Primary endpoint: Need for Additional Uterotonic Medications at 24 hours. Started Feb 2008; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT01733329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733329.